Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy

Whether two-drug therapy (clarithromycin and ethambutol) for Mycobacterium avium complex (MAC) pulmonary disease contributes to the development of macrolide-resistant MAC is unclear.

Source: Respiratory Medicine - May 13, 2020 Category: Respiratory Medicine Authors: Yasuhiro Ito, Seiichi Miwa, Masahiro Shirai, Miho Kanai, Kaoru Fujita, Hisano Ohba, Eriko Iwaizumi, Tomoko Oshima, Suguru Kojima, Takafumi Suda, Hiroshi Hayakawa Source Type: research